Breaking News Instant updates and real-time market news.

2022-03-31 08:08:23 ACLS Axcelis $77.48 / -3.44 (-4.25%) 08:08 03/31/22 03/31 08:08 03/31/22 08:08	Axcelis announces follow on shipments of Purion Power Series implanters Axcelis Technologies announced follow on shipments of the company's Purion XE high energy and Purion M medium current Power Series implanters to a leading power device chipmaker located in Japan. The systems will be used in high volume production of 300mm thin silicon wafer based MOSFET and IGBT devices for automotive and other power management applications.

2022-03-31 08:08:23

ACLS

Axcelis

$77.48 / -3.44 (-4.25%)

08:08

03/31/22

03/31

08:08

03/31/22

08:08

Axcelis announces follow on shipments of Purion Power Series implanters

Axcelis Technologies announced follow on shipments of the company's Purion XE high energy and Purion M medium current Power Series implanters to a leading power device chipmaker located in Japan. The systems will be used in high volume production of 300mm thin silicon wafer based MOSFET and IGBT devices for automotive and other power management applications.

OTHER BREAKING NEWS FROM THE FLY

Initiation	Sapiens initiated with an Underweight at JPMorgan » 06:06 12/01/22 12/01 06:06 12/01/22 06:06 SPNS Sapiens $19.46 / +0.21 (+1.09%) JPMorgan analyst Alexei… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SPNS Sapiens $19.46 / +0.21 (+1.09%) 11/28/22 Sapiens signs agreement with Toyota Insurance Spain to modernize its business 09/21/22 Sapiens announces five new tactical partnerships in North American market 09/06/22 Sapiens selected by AEGIS to automate, modernize reinsurance process SPNS Sapiens $19.46 / +0.21 (+1.09%) 08/08/22 Citi Sapiens price target lowered to $25 from $27 at Citi 02/24/22 Citi Sapiens price target lowered to $30 from $38 at Citi 12/14/21 JPMorgan Sapiens downgraded to Underweight from Neutral at JPMorgan 12/14/21 JPMorgan Sapiens downgraded to Underweight from Neutral at JPMorgan SPNS Sapiens $19.46 / +0.21 (+1.09%) 11/03/22 Sapiens reports Q3 adjusted EPS 30c, consensus 29c 08/03/22 Sapiens lowers FY22 revenue view to $480M-$485M from $495M-$500M 08/03/22 Sapiens reports Q2 non-GAAP EPS 27c, consensus 29c
Downgrade	Zebra Technologies downgraded to Underperform from Peer Perform at Wolfe Research » 06:06 12/01/22 12/01 06:06 12/01/22 06:06 ZBRA Zebra Technologies $270.15 / +3.36 (+1.26%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ZBRA Zebra Technologies $270.15 / +3.36 (+1.26%) 11/21/22 Zebra Technologies namesTami Froese Chief Supply Chain Officer 09/20/22 Zebra Technologies and ARC team to further biology research in Australia 07/05/22 InterDigital signs multi-year royalty bearing license with Zebra Technologies 06/30/22 Zebra Technologies to pay $360M in patent-related settlement with Honeywell ZBRA Zebra Technologies $270.15 / +3.36 (+1.26%) 11/03/22 UBS Zebra Technologies price target lowered to $445 from $485 at UBS 11/02/22 Needham Zebra Technologies price target lowered to $330 from $450 at Needham 11/02/22 Baird Zebra Technologies price target lowered to $300 from $330 at Baird 10/14/22 Morgan Stanley Zebra Technologies price target lowered to $225 from $335 at Morgan Stanley ZBRA Zebra Technologies $270.15 / +3.36 (+1.26%) 11/01/22 Zebra Technologies sees Q4 adjusted EPS $4.50 -$4.80, consensus $5.13 11/01/22 Zebra Technologies reports Q3 adjusted EPS $4.12, consensus $4.54 08/02/22 Zebra Technologies narrows FY22 sales growth view to 4%-6% 08/02/22 Zebra Technologies sees Q3 adjusted EPS $4.35 -$4.65, consensus $5.08
Hot Stocks	Big Lots sees Q4 comparable store sales down in low double-digit range » 06:06 12/01/22 12/01 06:06 12/01/22 06:06 BIG Big Lots $19.49 / +0.275 (+1.43%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BIG Big Lots $19.49 / +0.275 (+1.43%) 11/09/22 Big Lots announces new Chief Merchandising, Chief Marketing Officer 09/15/22 Big Lots, DoorDash announce new partnership 08/30/22 Big Lots sees Q3 comparable store sales down in low double-digit range BIG Big Lots $19.49 / +0.275 (+1.43%) 11/29/22 Deutsche Bank Big Lots price target lowered to $13 from $18 at Deutsche Bank 09/16/22 JPMorgan Big Lots price target raised to $9 from $8 at JPMorgan 08/24/22 Deutsche Bank Big Lots price target lowered to $18 from $23 at Deutsche Bank 06/21/22 Loop Capital Big Lots price target lowered to $22 from $27 at Loop Capital BIG Big Lots $19.49 / +0.275 (+1.43%) 06:03 Today Big Lots reports Q3 adjusted EPS ($2.99), consensus ($2.94) 08/30/22 Big Lots reports Q2 adjusted EPS ($2.28), consensus ($2.47) BIG Big Lots $19.49 / +0.275 (+1.43%) 08/30/22 What You Missed On Wall Street On Tuesday 08/30/22 What You Missed On Wall Street This Morning 06/11/22 Short Report: Redbox takes the mantle from GameStop as short-squeeze darling 08:00 Today Big Lots - BIG BIG Big Lots $19.49 / +0.275 (+1.43%) 11/10/22 Largest borrow rate increases among liquid names 10/26/22 Largest borrow rate increases among liquid names
Initiation	SpringsWorks Therapeutics initiated with a Buy at BofA » 06:06 12/01/22 12/01 06:06 12/01/22 06:06 SWTX SpringsWorks Therapeutics $24.16 / +0.72 (+3.07%) BofA analyst Alec… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SWTX SpringsWorks Therapeutics $24.16 / +0.72 (+3.07%) 11/01/22 Applied BioMath announces collaboration with SpringsWorks 09/29/22 SpringsWorks Therapeutics doses first patient in Phase 2 trial of nirogacestat 09/10/22 SpringWorks Therapeutics announces data from Phase 3 DeFi trial 09/07/22 SpringWorks Therapeutics trading resumes SWTX SpringsWorks Therapeutics $24.16 / +0.72 (+3.07%) 09/12/22 H.C. Wainwright SpringsWorks price target raised to $103 from $94 at H.C. Wainwright 08/09/22 H.C. Wainwright SpringsWorks Therapeutics price target lowered to $94 from $95 at H.C. Wainwright 06/06/22 H.C. Wainwright SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright 06/06/22 H.C. Wainwright Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright SWTX SpringsWorks Therapeutics $24.16 / +0.72 (+3.07%) 11/03/22 SpringsWorks Therapeutics reports Q3 EPS ($1.37), consensus ($1.32) 08/04/22 SpringsWorks Therapeutics reports Q2 EPS ($1.41), consensus ($1.20) SWTX SpringsWorks Therapeutics $24.16 / +0.72 (+3.07%) 06/24/22 Sell these stocks now, proven algorithm says 06/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Day One Biopharmaceuticals initiated with a Buy at BofA » 06:05 12/01/22 12/01 06:05 12/01/22 06:05 DAWN Day One Biopharmaceuticals $21.20 / +0.85 (+4.18%) BofA analyst Alec… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options DAWN Day One Biopharmaceuticals $21.20 / +0.85 (+4.18%) 10/17/22 Day One Biopharmaceuticals announces CRADA with NCI for tovorafenib 09/12/22 Day One Biopharmaceuticals appoints Nicholson as chairman 06/21/22 Day One announces closing of upsized public offering 06/12/22 Day One announces initial data from pivotal FIREFLY-1 trial of Tovorafenib DAWN Day One Biopharmaceuticals $21.20 / +0.85 (+4.18%) 06/20/22 Piper Sandler Day One Biopharmaceuticals price target raised to $40 from $35 at Piper Sandler 06/13/22 Wedbush Day One Biopharmaceuticals price target raised to $35 from $32 at Wedbush 06/13/22 Piper Sandler Piper reiterates $35 target on Day One after 'new high mark' data 06/13/22 JPMorgan JPMorgan sees Day One shares moving to mid-teens, low-$20s on data DAWN Day One Biopharmaceuticals $21.20 / +0.85 (+4.18%) 11/07/22 Day One Biopharmaceuticals reports Q3 EPS (53c), consensus (53c) 08/04/22 Day One Biopharmaceuticals reports Q2 EPS (60c), consensus (49c) 15 Jun DAWN Day One Biopharmaceuticals $21.20 / +0.85 (+4.18%) 09/12/22 Fly Insider: PVH, Autonation among week's notable insider trades 06/15/22 What You Missed On Wall Street On Wednesday 06/15/22 What You Missed On Wall Street This Morning 06/14/22 Fly Intel: Pre-market Movers DAWN Day One Biopharmaceuticals $21.20 / +0.85 (+4.18%) 08/26/22 Largest borrow rate increases among liquid names
Upgrade	Vertiv Holdings upgraded to Outperform from Peer Perform at Wolfe Research » 06:05 12/01/22 12/01 06:05 12/01/22 06:05 VRT Vertiv Holdings $13.87 / +0.68 (+5.16%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly VRT Vertiv Holdings $13.87 / +0.68 (+5.16%) 11/04/22 Vertiv Holdings director Deangelo acquires 71,600 class A shares 10/20/22 Vertiv Holdings rises 15.0% 10/20/22 Vertiv Holdings rises 9.2% 10/20/22 Vertiv Holdings rises 9.1% VRT Vertiv Holdings $13.87 / +0.68 (+5.16%) 10/27/22 Deutsche Bank Vertiv Holdings price target raised to $17 from $15 at Deutsche Bank 10/27/22 Cowen Vertiv Holdings upgraded to Outperform from Market Perform at Cowen 10/04/22 Deutsche Bank Vertiv Holdings price target lowered to $15 from $16 at Deutsche Bank 09/23/22 Cowen Vertiv Holdings price target lowered to $11.75 from $12.75 at Cowen VRT Vertiv Holdings $13.87 / +0.68 (+5.16%) 10/26/22 Vertiv Holdings cuts FY22 adjusted EPS view to 53c-59c from 61c-67c 10/26/22 Vertiv Holdings sees Q4 adjusted EPS $29c-35c, consensus 34c 10/26/22 Vertiv Holdings reports Q3 EPS 6c, consensus 21c 10/03/22 Vertiv Holdings backs Q3 adjusted EPS view 20c-26c, consensus 23c VRT Vertiv Holdings $13.87 / +0.68 (+5.16%) 10/20/22 Starboard seeking 'operational improvements' at Vertiv, Bloomberg reports VRT Vertiv Holdings $13.87 / +0.68 (+5.16%) 10/20/22 What You Missed On Wall Street On Thursday 10/20/22 What You Missed On Wall Street This Morning 10/03/22 What You Missed On Wall Street On Monday 10/03/22 What You Missed On Wall Street This Morning
Initiation	Duck Creek Technologies initiated with a Neutral at JPMorgan » 06:04 12/01/22 12/01 06:04 12/01/22 06:04 DCT Duck Creek Technologies $11.17 / +0.365 (+3.38%) JPMorgan analyst Alexei… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DCT Duck Creek Technologies $11.17 / +0.365 (+3.38%) 11/10/22 Duck Creek Technologies announces Mutual Benefit will utilize its SaaS solution 10/31/22 Duck Creek Technologies announces automated test integration with SPLICE 10/18/22 Duck Creek Technologies announces cloud-based integration with ExamWorks 09/26/22 Duck Creek Technologies announces partnership with Coaction Specialty Insurance DCT Duck Creek Technologies $11.17 / +0.365 (+3.38%) 10/13/22 RBC Capital Duck Creek Technologies price target lowered to $12 from $14 at RBC Capital 10/13/22 Needham Duck Creek Technologies price target lowered to $16 from $20 at Needham 10/13/22 DA Davidson Duck Creek Technologies price target lowered to $27 from $30 at DA Davidson 10/12/22 Barclays Duck Creek price target lowered to $14 from $21 at Barclays DCT Duck Creek Technologies $11.17 / +0.365 (+3.38%) 10/12/22 Duck Creek Technologies sees FY23 EPS 11c-13c, consensus 12c 10/12/22 Duck Creek Technologies sees Q1 EPS (1c)-0c, consensus 2c 10/12/22 Duck Creek Technologies reports Q4 EPS 3c, consensus 2c 06/29/22 Duck Creek Technologies sees FY22 EPS 9c-10c, consensus 10c DCT Duck Creek Technologies $11.17 / +0.365 (+3.38%) 10/12/22 Fly Intel: After-Hours Movers 07/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/30/22 What You Missed On Wall Street On Thursday 06/30/22 What You Missed On Wall Street This Morning
Downgrade	Saia downgraded to Underperform from Neutral at BofA » 06:03 12/01/22 12/01 06:03 12/01/22 06:03 SAIA Saia $243.09 / +8.79 (+3.75%) BofA analyst Ken Hoexter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SAIA Saia $243.09 / +8.79 (+3.75%) 10/31/22 Saia sees 2022 net capital expenditures $500M 09/07/22 Saia reports August LTL shipments per workday declined 1.9% 08/29/22 Saia LTL Freight opens new terminal in Franklin Park, Illinois 06/02/22 Saia reports May LTL shipments per workday increased 4.1% SAIA Saia $243.09 / +8.79 (+3.75%) 11/28/22 Deutsche Bank Saia price target raised to $296 from $281 at Deutsche Bank 11/17/22 Wolfe Research Wolfe reshuffles ratings in freight with five downgrades and one upgrade 11/17/22 Wolfe Research Saia downgraded to Peer Perform from Outperform at Wolfe Research 11/14/22 Deutsche Bank Saia price target raised to $281 from $245 at Deutsche Bank SAIA Saia $243.09 / +8.79 (+3.75%) 10/31/22 Saia reports Q3 EPS $3.67, consensus $3.70 07/27/22 Saia reports Q2 EPS $4.10, consensus $3.55 SAIA Saia $243.09 / +8.79 (+3.75%) 10/31/22 What You Missed On Wall Street On Monday 10/31/22 What You Missed On Wall Street This Morning 08/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Downgrade	Vontier downgraded to Peer Perform from Outperform at Wolfe Research » 06:03 12/01/22 12/01 06:03 12/01/22 06:03 VNT Vontier $19.62 / +0.52 (+2.72%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VNT Vontier $19.62 / +0.52 (+2.72%) 09/27/22 Neogen CFO Steve Quinlan to retire, David Naemura to succeed 08/31/22 Vontier completes acquisition of Invenco 08/12/22 Vontier appoints Anshooman Aga as CFO 07/28/22 Vontier names Hani Joakim as Chief Technology Officer VNT Vontier $19.62 / +0.52 (+2.72%) 10/10/22 Citi Vontier price target lowered to $23 from $29 at Citi 10/03/22 Barclays Vontier price target lowered to $30 from $33 at Barclays 07/08/22 Barclays Vontier price target lowered to $33 from $39 at Barclays 04/04/22 Barclays Vontier price target lowered to $40 from $42 at Barclays VNT Vontier $19.62 / +0.52 (+2.72%) 11/03/22 Vontier sees Q4 adjusted EPS 73c-78c, consensus 93c 11/03/22 Vontier cuts FY22 adjusted EPS view to $3.00-$3.05 from $3.20-$3.30 11/03/22 Vontier reports Q3 adjusted EPS 86c, consensus 85c 08/04/22 Vontier sees 2022 revenue $80M, consensus $3.19B
Earnings	Big Lots reports Q3 adjusted EPS ($2.99), consensus ($2.94) » 06:03 12/01/22 12/01 06:03 12/01/22 06:03 BIG Big Lots $19.49 / +0.275 (+1.43%) Reports Q3 revenue $1.2B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BIG Big Lots $19.49 / +0.275 (+1.43%) 11/09/22 Big Lots announces new Chief Merchandising, Chief Marketing Officer 09/15/22 Big Lots, DoorDash announce new partnership 08/30/22 Big Lots sees Q3 comparable store sales down in low double-digit range BIG Big Lots $19.49 / +0.275 (+1.43%) 11/29/22 Deutsche Bank Big Lots price target lowered to $13 from $18 at Deutsche Bank 09/16/22 JPMorgan Big Lots price target raised to $9 from $8 at JPMorgan 08/24/22 Deutsche Bank Big Lots price target lowered to $18 from $23 at Deutsche Bank 06/21/22 Loop Capital Big Lots price target lowered to $22 from $27 at Loop Capital BIG Big Lots $19.49 / +0.275 (+1.43%) 08/30/22 Big Lots reports Q2 adjusted EPS ($2.28), consensus ($2.47) BIG Big Lots $19.49 / +0.275 (+1.43%) 08/30/22 What You Missed On Wall Street On Tuesday 08/30/22 What You Missed On Wall Street This Morning 06/11/22 Short Report: Redbox takes the mantle from GameStop as short-squeeze darling 08:00 Today Big Lots - BIG BIG Big Lots $19.49 / +0.275 (+1.43%) 11/10/22 Largest borrow rate increases among liquid names 10/26/22 Largest borrow rate increases among liquid names

Initiation	scPharmaceuticals initiated with an Outperform at Cowen » 06:02 12/01/22 12/01 06:02 12/01/22 06:02 SCPH scPharmaceuticals $7.33 / +0.17 (+2.37%) Cowen analyst Ken… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SCPH scPharmaceuticals $7.33 / +0.17 (+2.37%) 11/22/22 scPharmaceuticals announces pricing of $50M public offering 11/21/22 scPharmaceuticals falls 16% to $5.10 after announcing common stock offering 10/10/22 scPharmaceuticals announces $100M debt financing agreement 10/10/22 scPharmaceuticals announces FDA approval of FUROSCIX SCPH scPharmaceuticals $7.33 / +0.17 (+2.37%) 11/10/22 H.C. Wainwright scPharmaceuticals price target raised to $18 from $15 at H.C. Wainwright 10/21/22 Jefferies scPharmaceuticals assumed with a Buy, $14 price target at Jefferies 10/20/22 Jefferies scPharmaceuticals assumed with a Buy at Jefferies 10/11/22 Maxim scPharmaceuticals price target raised to $13 from $10 at Maxim SCPH scPharmaceuticals $7.33 / +0.17 (+2.37%) 08/09/22 scPharmaceuticals sees 2022 net loss $43M-$48M 08/09/22 scPharmaceuticals reports Q2 EPS (35c) vs. (26c) last year 22 Nov SCPH scPharmaceuticals $7.33 / +0.17 (+2.37%) 11/22/22 Fly Intel: Pre-market Movers 11/21/22 Fly Intel: After-Hours Movers
Initiation	Guidewire initiated with an Overweight at JPMorgan » 06:02 12/01/22 12/01 06:02 12/01/22 06:02 GWRE Guidewire $59.30 / +2.37 (+4.16%) JPMorgan analyst Alexei… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GWRE Guidewire $59.30 / +2.37 (+4.16%) 10/24/22 Guidewire announces strategic payments partnership with One Inc 10/21/22 Guidewire appoints David Laker as chief sales officer 09/28/22 Guidewire announces $200M accelerated share buyback program 09/22/22 Guidewire announces $400M share repurchase program GWRE Guidewire $59.30 / +2.37 (+4.16%) 09/12/22 Citi Guidewire price target lowered to $79 from $88 at Citi 09/08/22 Baird Guidewire price target lowered to $81 from $99 at Baird 09/07/22 JMP Securities Guidewire price target lowered to $95 from $110 at JMP Securities 09/07/22 RBC Capital Guidewire price target lowered to $100 from $125 at RBC Capital GWRE Guidewire $59.30 / +2.37 (+4.16%) 09/06/22 Guidewire sees FY23 revenue $885M-$895M, consensus $882.23M 09/06/22 Guidewire sees Q1 revenue $190M-$195M, consensus $187.72M 09/06/22 Guidewire reports Q4 adjusted EPS (3c), consensus (1c) 09/06/22 Notable companies reporting after market close GWRE Guidewire $59.30 / +2.37 (+4.16%) 09/22/22 Fly Intel: After-Hours Movers 09/07/22 What You Missed On Wall Street On Wednesday 09/07/22 What You Missed On Wall Street This Morning 06/07/22 Fly Intel: After-Hours Movers 12/06/22 Guidewire - GWRE 12/20/22 Guidewire Software, Inc.
Downgrade	Regal Rexnord downgraded to Peer Perform from Outperform at Wolfe Research » 06:02 12/01/22 12/01 06:02 12/01/22 06:02 RRX Regal Rexnord $130.96 / +3.27 (+2.56%) , AIMC Altra Industrial Motion $58.51 / +0.24 (+0.41%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RRX AIMC RRX Regal Rexnord $130.96 / +3.27 (+2.56%) 11/30/22 Regal Rexnord to explore alternatives for global motors, generators business 10/27/22 Altra Industrial Motion to be acquired by Regal Rexnord for $62 per share or $5B AIMC Altra Industrial Motion $58.51 / +0.24 (+0.41%) 10/27/22 Altra Industrial Motion to be acquired by Regal Rexnord for $62 per share or $5B RRX AIMC RRX Regal Rexnord $130.96 / +3.27 (+2.56%) 11/02/22 Baird Regal Rexnord price target lowered to $167 from $174 at Baird 08/03/22 Baird Regal Rexnord price target raised to $158 from $146 at Baird 08/03/22 Barclays Regal Rexnord price target raised to $157 from $140 at Barclays 07/08/22 Barclays Regal Rexnord price target lowered to $140 from $150 at Barclays AIMC Altra Industrial Motion $58.51 / +0.24 (+0.41%) 11/01/22 Baird Altra Industrial Motion downgraded to Neutral on buyout at Baird 11/01/22 Baird Altra Industrial Motion downgraded to Neutral from Outperform at Baird 08/25/22 Loop Capital Loop Capital starts 'undervalued' Altra Industrial Motion with Buy 08/25/22 Loop Capital Altra Industrial Motion initiated with a Buy at Loop Capital RRX AIMC RRX Regal Rexnord $130.96 / +3.27 (+2.56%) 10/31/22 Regal Rexnord raises FY22 EPS view to $10.35-$10.75 from $10.20-$10.80 10/31/22 Regal Rexnord reports Q3 EPS $2.66, consensus $2.61 08/01/22 Regal Rexnord raises FY22 adjusted EPS to $10.20-$10.80 from $10.10-$10.70 08/01/22 Regal Rexnord reports Q2 adjusted EPS $2.76, consensus $2.61 AIMC Altra Industrial Motion $58.51 / +0.24 (+0.41%) 10/31/22 Altra Industrial Motion reports Q3 adjusted EPS 80c, consensus 83c 10/27/22 Altra Industrial Motion reports preliminary Q3 revenue $466.3M, consensus $471M 07/28/22 Altra Industrial Motion sees 2022 adjusted EPS $3.35-$3.50, consensus $3.29 07/28/22 Altra Industrial Motion Reports Q2 adjusted EPS 84c, consensus 84c RRX RRX Regal Rexnord $130.96 / +3.27 (+2.56%) 07/27/22 Axalta back on M&A 'watchlist' at Dealreporter after naming interim CEO RRX AIMC RRX Regal Rexnord $130.96 / +3.27 (+2.56%) 10/27/22 What You Missed On Wall Street On Thursday 10/27/22 What You Missed On Wall Street This Morning AIMC Altra Industrial Motion $58.51 / +0.24 (+0.41%) 10/27/22 What You Missed On Wall Street On Thursday 10/27/22 What You Missed On Wall Street This Morning 12/14/22 Midwest Industrial Virtual Summit
Hot Stocks	Essential Properties Realty Trust raises dividend 1.9% to 27.5c per share » 06:02 12/01/22 12/01 06:02 12/01/22 06:02 EPRT Essential Properties Realty Trust $23.22 / +0.57 (+2.52%) Essential Properties… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly EPRT Essential Properties Realty Trust $23.22 / +0.57 (+2.52%) 09/12/22 Essential Properties Realty Trust announces partnership with Budderfly 06/06/22 Essential Properties Realty Trust increases quarterly dividend to 27c per share EPRT Essential Properties Realty Trust $23.22 / +0.57 (+2.52%) 11/11/22 Truist Essential Properties price target lowered to $25 from $28 at Truist 10/13/22 Mizuho Essential Properties Realty Trust upgraded to Buy from Neutral at Mizuho 09/27/22 Evercore ISI Essential Properties Realty Trust price target lowered to $24 from $26 at Evercore ISI 09/12/22 Evercore ISI Essential Properties price target raised to $26 from $24 at Evercore ISI EPRT Essential Properties Realty Trust $23.22 / +0.57 (+2.52%) 10/27/22 Essential Properties sees FY23 AFFO $1.58-$1.64, consensus $1.64 10/27/22 Essential Properties backs FY22 AFFO view $1.52-$1.54, consensus $1.55 10/27/22 Essential Properties reports Q3 AFFO 38c, consensus 38c 07/28/22 Essential Properties Realty Trust raises FY22 FFO view to $1.52-$1.54 02 Aug EPRT Essential Properties Realty Trust $23.22 / +0.57 (+2.52%) 08/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Greenwich LifeSciences extends lock-up of directors, officers to end of 2023 » 06:01 12/01/22 12/01 06:01 12/01/22 06:01 GLSI Greenwich LifeSciences $13.89 / +0.17 (+1.24%) Greenwich LifeSciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GLSI Greenwich LifeSciences $13.89 / +0.17 (+1.24%) 08/11/22 Greenwich LifeSciences commences Phase III clincial trial of GLSI-100 08/03/22 Greenwich Life actively preparing additional US sites for Flamingo-01 trial 07/12/22 Greenwich LifeSciences Inc trading resumes 07/12/22 Greenwich LifeSciences Inc trading halted, volatility trading pause GLSI Greenwich LifeSciences $13.89 / +0.17 (+1.24%) 07/12/22 H.C. Wainwright H.C. Wainwright reiterates $78 target on Greenwich after clinical hold lift
Recommendations	Liberty SiriusXM price target raised to $62 from $60 at Citi » 06:00 12/01/22 12/01 06:00 12/01/22 06:00 LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) Citi analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 11/17/22 Liberty Media to pursue split-off of Atlanta Braves to create new stock group 11/02/22 Breach Inlet calls on Liberty Media board to spinoff Liberty Braves LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 06:00 Today Citi Sirius XM downgraded to Sell from Buy at Citi 11/09/22 Deutsche Bank Liberty SiriusXM should be bought into investor day, says Deutsche Bank 11/07/22 Citi Citi ups Liberty SiriusXM target, opens 'positive Catalyst Watch' 08/23/22 Deutsche Bank Deutsche sees 38% upside in Liberty SiriusXM with management action LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 11/04/22 Liberty SiriusXM reports Q3 EPS 6c, consensus 86c 08/05/22 Liberty SiriusXM reports Q2 EPS 7c vs. (3c) last year LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 11/17/22 Live Nation shareholder says high demand to blame for Swift issues, CNBC says
Downgrade	Hub Group downgraded to Underperform from Peer Perform at Wolfe Research » 06:00 12/01/22 12/01 06:00 12/01/22 06:00 HUBG Hub Group $84.14 / +1.29 (+1.56%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events HUBG Hub Group $84.14 / +1.29 (+1.56%) 11/17/22 Hub Group's David Yeager to retire as CEO, Phillip Yeager to succeed 08/22/22 Hub Group acquires TAGG Logistics for $103M 07/15/22 Hub Group opens second headquarters building HUBG Hub Group $84.14 / +1.29 (+1.56%) 11/17/22 Wolfe Research Wolfe reshuffles ratings in freight with five downgrades and one upgrade 11/17/22 Wolfe Research Hub Group downgraded to Peer Perform from Outperform at Wolfe Research 10/11/22 Barclays Hub Group price target lowered to $75 from $82 at Barclays 08/10/22 Susquehanna Hub Group price target raised to $117 from $115 at Susquehanna HUBG Hub Group $84.14 / +1.29 (+1.56%) 10/27/22 Hub Group sees FY22 EPS $10.40-$10.60, consensus $10.37 10/27/22 Hub Group reports Q3 diluted EPS $2.61, consensus $2.46 08/03/22 Hub Group raises FY22 EPS view to $10.00-$10.50, consensus $9.59 08/03/22 Hub Group reports Q2 EPS $3.03, consensus $2.54 00:00 Today Hub Group
Downgrade	Sirius XM downgraded to Sell from Buy at Citi » 06:00 12/01/22 12/01 06:00 12/01/22 06:00 SIRI Sirius XM $6.49 / +0.07 (+1.09%) , LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) Citi analyst Jason… Citi analyst Jason Bazinet double downgraded Sirius XM (SIRI) to Sell from Buy with a price target of $6, down from $7. Once Liberty creates Liberty Live Nation in 2023, the analyst expects Sirius to enter into a share exchange with the new Liberty SiriusXM (LSXMA). He expects Sirius XM's share count to decline by 10% but that its leverage will increase to 4.8-times debt-to-EBITDA. As a result, the Street will pivot from levered free cash flow to enterprise value to EBITDA as the primary valuation metric, Bazinet tells investors in a research note. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SIRI LSXMA SIRI Sirius XM $6.49 / +0.07 (+1.09%) 11/01/22 Sirius XM continues to expect positive 2022 self-pay net subscriber additions 11/01/22 Sirius XM reports Q3 self-pay subscribers 32.3M 11/01/22 Sirius XM raises quarterly cash dividend 10% 10/31/22 Sirius XM to be standard in-dash feature across full lineup of Lucid vehicles LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 11/17/22 Liberty Media to pursue split-off of Atlanta Braves to create new stock group 11/02/22 Breach Inlet calls on Liberty Media board to spinoff Liberty Braves SIRI LSXMA SIRI Sirius XM $6.49 / +0.07 (+1.09%) 11/02/22 Deutsche Bank Sirius XM price target lowered to $7.50 from $8 at Deutsche Bank 11/02/22 Pivotal Research Sirius XM price target lowered to $6.75 from $7.10 at Pivotal Research 08/23/22 Deutsche Bank Deutsche sees 38% upside in Liberty SiriusXM with management action 08/08/22 Barclays Liberty SiriusXM price target raised to $61 from $58 at Barclays LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 11/09/22 Deutsche Bank Liberty SiriusXM should be bought into investor day, says Deutsche Bank 11/07/22 Citi Citi ups Liberty SiriusXM target, opens 'positive Catalyst Watch' 08/23/22 Deutsche Bank Deutsche sees 38% upside in Liberty SiriusXM with management action 08/08/22 Credit Suisse Liberty SiriusXM price target lowered to $52 from $64 at Credit Suisse SIRI LSXMA SIRI Sirius XM $6.49 / +0.07 (+1.09%) 11/01/22 Sirius XM reports Q3 adjusted EPS 7c, consensus 8c 11/01/22 Sirius XM sees FY22 revenue $9B, consensus $9.04B 11/01/22 Sirius XM reports Q3 diluted EPS 6c, consensus 8c 10/31/22 Notable companies reporting before tomorrow's open LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 11/04/22 Liberty SiriusXM reports Q3 EPS 6c, consensus 86c 08/05/22 Liberty SiriusXM reports Q2 EPS 7c vs. (3c) last year SIRI LSXMA SIRI Sirius XM $6.49 / +0.07 (+1.09%) 08/31/22 James Van Der Beek sues SiriusXM over podcast deal, THR reports LSXMA Liberty SiriusXM $43.85 / +0.81 (+1.88%) 11/17/22 Live Nation shareholder says high demand to blame for Swift issues, CNBC says SIRI SIRI Sirius XM $6.49 / +0.07 (+1.09%) 11/28/22 Fly Insider: Autoscope, Archer Aviation among week's notable insider trades 11/01/22 Fly Intel: Pre-market Movers 08/07/22 Short Report: Bed Bath Beyond in short-squeeze spotlight SIRI SIRI Sirius XM $6.49 / +0.07 (+1.09%) 11/18/22 Notable open interest changes for November 18th 11/16/22 Sirius XM call volume above normal and directionally bullish 11/14/22 Sirius XM put volume heavy and directionally bearish 11/10/22 Largest borrow rate increases among liquid names
Periodicals	Zuckerberg says Apple's app policies 'not sustainable,' Axios reports » 05:58 12/01/22 12/01 05:58 12/01/22 05:58 AAPL Apple $148.00 / +6.81 (+4.82%) , META Meta Platforms $118.10 / +8.64 (+7.89%) , TSLA Tesla $194.71 / +13.87 (+7.67%) , TWTR Twitter $53.71 / + (+0.00%) Meta (META) CEO Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AAPL META TSLA TWTR AAPL Apple $148.00 / +6.81 (+4.82%) 11/30/22 Musk says Apple CEO never considered removing Twitter from App Store 11/28/22 Musk says Apple 'threatened to withhold Twitter' from App Store 11/23/22 Apple exec sells $3.0M in common stock 11/22/22 U.K.'s CMA launches probe into cloud gaming, mobile browsers META Meta Platforms $118.10 / +8.64 (+7.89%) 11/28/22 Meta fined EUR265M over Facebook data leak involving more than 533M users 11/23/22 German regulator says Meta to allow VR headset without a Facebook account 11/22/22 EC Chief von der Leyen, confirms TikTok's data transfers being investigated 11/22/22 Meta communications director denies report that Zuckerberg will resign next year TSLA Tesla $194.71 / +13.87 (+7.67%) 11/28/22 Musk says Apple 'threatened to withhold Twitter' from App Store 11/25/22 Tesla to recall just over 80,000 vehicles in China 11/17/22 EU passenger car registrations up 12.2% in October 11/16/22 Cathie Wood's ARK Investment bought 3.9K shares of Tesla today TWTR Twitter $53.71 / + (+0.00%) 11/30/22 Musk says Apple CEO never considered removing Twitter from App Store 11/30/22 Twitter says transparent approach to platform changes 'healthy' 11/28/22 Musk says Apple 'threatened to withhold Twitter' from App Store 11/22/22 EC Chief von der Leyen, confirms TikTok's data transfers being investigated AAPL META TSLA TWTR AAPL Apple $148.00 / +6.81 (+4.82%) 04:51 Today Piper Sandler Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler 11/30/22 Wedbush China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush 11/30/22 Baird Apple estimates lowered due to ongoing assembly challenges, says Baird 11/29/22 Deutsche Bank Apple Pay taking e-commerce share from PayPal, says Deutsche Bank META Meta Platforms $118.10 / +8.64 (+7.89%) 11/15/22 Morgan Stanley Meta Platforms price target lowered to $100 from $105 at Morgan Stanley 11/10/22 Canaccord Meta Platforms price target lowered to $170 from $200 at Canaccord 11/09/22 Itau BBA Meta Platforms price target raised to $120 from $102 at Itau BBA 11/09/22 Baird Meta layoffs represent 'significant shift in strategy,' says Baird TSLA Tesla $194.71 / +13.87 (+7.67%) 11/29/22 Bernstein Tesla risk/reward 'more balanced' after 48% drop, says Bernstein 11/28/22 Jefferies XPeng downgraded to Underperform at Jefferies ahead of 'challenging year' 11/23/22 Morgan Stanley Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff 11/23/22 Citi Tesla upgraded to Neutral from Sell at Citi TWTR Twitter $53.71 / + (+0.00%) 11/23/22 Morgan Stanley Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff 10/31/22 Gordon Haskett Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn 10/21/22 Wedbush Twitter deal still 'brutal situation' for Tesla holders, Wedbush says 10/18/22 Gordon Haskett Bilson sees Tesla share sale coming with Musk $8B short for Twitter AAPL META TSLA TWTR AAPL Apple $148.00 / +6.81 (+4.82%) 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close 07/28/22 Apple reports Q3 EPS $1.20, consensus $1.16 07/28/22 Notable companies reporting after market close META Meta Platforms $118.10 / +8.64 (+7.89%) 11/09/22 Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B 10/26/22 Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B 10/26/22 Meta Platforms reports Q3 EPS $1.64, consensus $1.89 10/26/22 Notable companies reporting after market close TSLA Tesla $194.71 / +13.87 (+7.67%) 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 10/19/22 Notable companies reporting after market close 07/20/22 Tesla reports Q2 EPS $2.27, consensus $1.85 07/20/22 Notable companies reporting after market close TWTR Twitter $53.71 / + (+0.00%) 07/22/22 Twitter reports Q2 EPS (8c), consensus 14c 07/21/22 Notable companies reporting before tomorrow's open 07/21/22 Notable companies reporting before tomorrow's open AAPL META TSLA TWTR AAPL Apple $148.00 / +6.81 (+4.82%) 05:52 Today TSMC plans to produce 4nm chips at Arizona plant, Bloomberg reports 11/30/22 Roblox nabs Apple executive for key engineering role, Axios reports 11/30/22 Pitaro says ESPN 'not currently engaged' on Sunday Ticket, Bloomberg reports 11/30/22 DeSantis criticizes Apple for allegedly threatening Twitter, Forbes reports META Meta Platforms $118.10 / +8.64 (+7.89%) 11/30/22 Meta giving up some offices at Manhattan's Hudson Yards, Bloomberg reports 11/22/22 H&R Block, TaxAct sending users' information to Facebook, The Markup reports 11/17/22 Meta fires more than two dozen employees for hijacking user accounts, WSJ says 11/15/22 FBI director tells U.S lawmakers 'extremely concerned' about TikTok, CNBC says TSLA Tesla $194.71 / +13.87 (+7.67%) 11/30/22 Musk under renewed pressure from EU, U.S. over Twitter purchase, FT says 11/29/22 Tesla-Annex Semiconductor JV 'probably not real,' DigiTimes reports 11/28/22 South Korea's Yoon tells Reuters country to offer 'tailored' incentives to Tesla 11/28/22 Tesla developing revamped Model 3, Reuters reports TWTR Twitter $53.71 / + (+0.00%) 11/30/22 Musk under renewed pressure from EU, U.S. over Twitter purchase, FT says 11/30/22 DeSantis criticizes Apple for allegedly threatening Twitter, Forbes reports 11/21/22 Twitter reinstates former president's account, Reuters reports 11/17/22 Odds of Twitter 'breaking' in near future 'very high,' Verge reports AAPL META TSLA TWTR AAPL Apple $148.00 / +6.81 (+4.82%) 11/30/22 #SocialStocks: Twitter and Apple spar over advertising, censorship 11/30/22 What You Missed On Wall Street This Morning 11/29/22 What You Missed On Wall Street On Tuesday 11/28/22 What You Missed On Wall Street On Monday META Meta Platforms $118.10 / +8.64 (+7.89%) 11/30/22 #SocialStocks: Twitter and Apple spar over advertising, censorship 11/23/22 #SocialStocks: TikTok data transfers under investigation in EU 11/22/22 What You Missed On Wall Street On Tuesday 11/17/22 What You Missed On Wall Street On Thursday TSLA Tesla $194.71 / +13.87 (+7.67%) 11/28/22 What You Missed This Week in EVs and Clean Energy 11/25/22 What You Missed On Wall Street On Friday 11/23/22 What You Missed On Wall Street On Wednesday 11/23/22 #SocialStocks: TikTok data transfers under investigation in EU TWTR Twitter $53.71 / + (+0.00%) 11/30/22 #SocialStocks: Twitter and Apple spar over advertising, censorship 11/30/22 What You Missed On Wall Street This Morning 11/23/22 #SocialStocks: TikTok data transfers under investigation in EU 11/16/22 What You Missed On Wall Street On Wednesday AAPL META TSLA TWTR AAPL Apple $148.00 / +6.81 (+4.82%) 11/30/22 Notable open interest changes for November 30th 11/30/22 Apple put buyer realizes 38% same-day gains 11/29/22 Notable open interest changes for November 29th 11/28/22 Notable open interest changes for November 28th META Meta Platforms $118.10 / +8.64 (+7.89%) 11/09/22 Early notable gainers among liquid option names on November 9th 11/09/22 Unusually active option classes on open November 9th 11/07/22 Early notable gainers among liquid option names on November 7th 11/07/22 Notable open interest changes for November 7th TSLA Tesla $194.71 / +13.87 (+7.67%) 11/30/22 Notable open interest changes for November 30th 11/29/22 Notable open interest changes for November 29th 11/29/22 Tesla put buyer realizes 37% same-day gains 11/28/22 Notable open interest changes for November 28th TWTR Twitter $53.71 / + (+0.00%) 11/22/22 Two new option listings and option delistings on November 22nd 10/27/22 Unusually active option classes on open October 27th 10/24/22 Notable open interest changes for October 24th 10/21/22 Notable open interest changes for October 21st
Initiation	Fusion Pharmaceuticals resumed with a Buy at B. Riley » 05:56 12/01/22 12/01 05:56 12/01/22 05:56 FUSN Fusion Pharmaceuticals $2.25 / +0.04 (+1.81%) B. Riley analyst Yuan Zhi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FUSN Fusion Pharmaceuticals $2.25 / +0.04 (+1.81%) 11/07/22 Fusion Pharmaceuticals names Dmitri Bobilev, M.D. as Chief Medical Officer 08/29/22 Fusion announces first patient dosed in Phase 1/2 study of FPI-1966 06/23/22 Fusion Pharmaceuticals' IND for FPI-2059 cleared by FDA 06/14/22 Fusion announces presentation from cold antibody sub-study of FPI-1434 FUSN Fusion Pharmaceuticals $2.25 / +0.04 (+1.81%) 11/30/22 SVB Securities Fusion Pharmaceuticals initiated with an Outperform at SVB Securities 09/15/22 Truist Truist starts Fusion Pharmaceuticals at Buy with $10 price target 09/15/22 Truist Fusion Pharmaceuticals initiated with a Buy at Truist 09/06/22 JonesTrading Fusion Pharmaceuticals initiated with a Buy at JonesTrading FUSN Fusion Pharmaceuticals $2.25 / +0.04 (+1.81%) 11/08/22 Fusion Pharmaceuticals reports Q3 EPS (55c), consensus (50c) 08/09/22 Fusion Pharmaceuticals reports Q2 EPS (44c), consensus (53c) 12/06/22 Fusion Pharmaceuticals

General news	Energy Action: » 05:55 12/01/22 12/01 05:55 12/01/22 05:55 $ECON Economic Data / + Energy Action: Oil prices… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 11/04/22 Fed's Evans says smaller rate hikes make sense, Reuters reports 10/22/22 Fed set to raise rates by 0.75 point, discuss size of future hikes, WSJ says 10/10/22 JPMorgan CEO tells CNBC U.S. recession likely in 6 to 9 months 09/07/22 Fed Beige Book says price levels 'remained highly elevated' $ECON Economic Data / + 11/30/22 What You Missed On Wall Street On Wednesday 11/28/22 What You Missed On Wall Street On Monday 11/28/22 What You Missed On Wall Street This Morning 11/02/22 What You Missed On Wall Street On Wednesday
Conference/Events	Kinsale Capital Group management to meet with Truist » 05:55 12/01/22 12/01 05:55 12/01/22 05:55 KNSL Kinsale Capital Group $307.71 / +4.7 (+1.55%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate Events KNSL Kinsale Capital Group $307.71 / +4.7 (+1.55%) 10/31/22 Truist Kinsale Capital Group price target raised to $335 from $285 at Truist 10/31/22 RBC Capital Kinsale Capital Group price target raised to $350 from $275 at RBC Capital 08/15/22 Compass Point Kinsale Capital Group downgraded to Neutral from Buy at Compass Point 08/01/22 Truist Kinsale Capital Group price target raised to $285 from $270 at Truist KNSL Kinsale Capital Group $307.71 / +4.7 (+1.55%) 10/27/22 Kinsale Capital Group reports Q3 EPS $1.64, consensus $1.30 07/28/22 Kinsale Capital reports Q2 operating EPS $1.92, consensus $1.62 11 Nov 00:00 Today Kinsale Capital Group
Conference/Events	Endava management to meet with William Blair » 05:55 12/01/22 12/01 05:55 12/01/22 05:55 DAVA Endava $76.25 / +5.24 (+7.38%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DAVA Endava $76.25 / +5.24 (+7.38%) 10/06/22 Endava acquires Lexicon Digital and Lexicon Consolidated, terms undisclosed DAVA Endava $76.25 / +5.24 (+7.38%) 11/21/22 Citi Endava price target lowered to $105 from $110 at Citi 11/16/22 Susquehanna Endava price target raised to $120 from $110 at Susquehanna 09/28/22 Morgan Stanley Endava price target lowered to $95 from $130 at Morgan Stanley 09/28/22 Deutsche Bank Endava price target lowered to $78 from $94 at Deutsche Bank DAVA Endava $76.25 / +5.24 (+7.38%) 11/15/22 Endava reports Q1 EPS GBP0.55 vs GBP0.36 in the prior year 09/27/22 Endava sees FY23 adjusted EPS GBP 2.35-GBP 2.38 09/27/22 Endava sees Q1 adjusted EPS GBP 0.50-GBP 0.51 09/27/22 Endava reports Q4 adjusted EPS GBP 0.51 vs. GBP 0.41 last year 12/12/22 Digital Engineering Services Virtual Summit 00:00 Today Endava
Conference/Events	Kadant management to meet with William Blair » 05:55 12/01/22 12/01 05:55 12/01/22 05:55 KAI Kadant $191.98 / +3.255 (+1.72%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events KAI Kadant $191.98 / +3.255 (+1.72%) 11/03/22 Barrington Kadant price target lowered to $229 from $239 at Barrington 09/19/22 Barrington Kadant price target lowered to $239 from $248 at Barrington 05/05/22 Barrington Kadant price target raised to $250 from $240 at Barrington KAI Kadant $191.98 / +3.255 (+1.72%) 11/01/22 Kadant narrows FY22 adjusted EPS view to $8.80-$8.97 from $8.80-$8.90 11/01/22 Kadant reports Q3 adjusted EPS $2.38, consensus $2.12 08/02/22 Kadant reaffirms FY22 adjusted EPS view $8.80-$9.00, consensus $8.95 08/02/22 Kadant reports Q2 adjusted EPS $2.24, consensus $2.04 00:00 Today Kadant
Downgrade	Hubbell downgraded to Underperform from Peer Perform at Wolfe Research » 05:54 12/01/22 12/01 05:54 12/01/22 05:54 HUBB Hubbell $253.98 / +4.51 (+1.81%) Wolfe Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly HUBB Hubbell $253.98 / +4.51 (+1.81%) 10/21/22 Hubbell board approves share repurchase authorization of up to $300M 10/21/22 Hubbell announces 7% dividend increase HUBB Hubbell $253.98 / +4.51 (+1.81%) 11/17/22 UBS Hubbell price target raised to $254 from $200 at UBS 10/27/22 Wells Fargo Hubbell price target raised to $215 from $196 at Wells Fargo 10/26/22 Mizuho Hubbell price target raised to $252 from $220 at Mizuho 10/19/22 JPMorgan JPMorgan double downgrades Hubbell with risks being ignored HUBB Hubbell $253.98 / +4.51 (+1.81%) 10/25/22 Hubbell raises FY22 adjusted EPS view $10.25-$10.45 from $9.40-$9.80 10/25/22 Hubbell reports Q3 adjusted EPS $3.08, consensus $2.71 09/16/22 Hubbell CFO says full year guidance 'going to prove to be conservative' 07/26/22 Hubbell raises FY22 adjusted EPS guidance $9.40-$9.80 from $9.00-$9.40 HUBB Hubbell $253.98 / +4.51 (+1.81%) 06/07/22 What You Missed On Wall Street On Tuesday 06/07/22 What You Missed On Wall Street This Morning

Events

Earnings calls, analyst events, roadshows and more

Today at 07:30

Challenger Job-Cut Report Level: November 2022 Government Event
CM
Today at 07:30

CIBC - CM Conference Calls
YI
Today at 07:30

111, Inc. - YI Conference Calls
FFWM
Today at 07:30

First Foundation Firm Sponsored Meetings

Boston, MA
BIG
Today at 08:00

Big Lots - BIG Conference Calls
VSCO
Today at 08:00

Victoria's Secret - VSCO Conference Calls
SCWX
Today at 08:00

Secureworks - SCWX Conference Calls
Today at 08:30

Core PCE Price Index Y/Y: October 2022 Government Event
Today at 08:30

Personal Income M/M: October 2022 Government Event
Today at 08:30

Personal Consumption Expenditures M/M: October 2022 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	TCRT X TCRT Alaunos Therapeutics Spot Secondary Managers: Cantor Fitzgerald Priced at: $.65 24.228M Shares
Tues	ASAI X ASAI Sendas Distribuidora Secondary Managers: Itau BBA, BTG Pactual & JPMorgan, Safra Securities, Santander Priced at: $17.90 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASPN X ASPN Aspen Aerogels Spot Secondary Managers: Cowen & Barclays Priced at: $9.50 25.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASTS X ASTS AST SpaceMobile Spot Secondary Managers: B. Riley Priced at: $5.50 13.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AURA X AURA Aura Biosciences Spot Secondary Managers: SVB Securities, Cowen & Evercore ISI, JMP Securities, BTIG Priced at: $12.00 6.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	AZYO X AZYO Aziyo Biologics Spot Secondary Managers: Cantor Fitzgerald $6.90 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTO X CTO CTO Realty Growth Spot Secondary Managers: Wells Fargo & Raymond James $19.00-20.00 2.5M Shares FREY X FREY Freyr Battery Spot Secondary Managers: Credit Suisse, BofA & Morgan Stanley $11.25-11.75 13.5M Shares ISEE X ISEE Iveric bio Spot Secondary Managers: Cowen & Stifel $21.50-22.50 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NTLA X NTLA Intellia Therapeutics Spot Secondary Managers: Goldman Sachs $45.80-47.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SHLS X SHLS Shoals Technologies Secondary Managers: JPMorgan, Guggenheim & Morgan Stanley $28.97 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Axcelis announces follow on shipments of Purion Power Series implanters

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access